台股 » 個股 » 旭富 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

旭富

(4119)
可現股當沖
  • 股價
    78.3
  • 漲跌
    ▲0.3
  • 漲幅
    +0.38%
  • 成交量
    76
  • 產業
    上市 生技醫療類股
  • 353人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
旭富 (4119)籌碼相關-元大-花蓮 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw05/0405/1806/0106/1406/2807/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1412/2801/1002/0402/1602/2603/1003/2004/0104/037577.58082.58587.590May '24Jul '24Sep '24Nov '24Jan '25Mar '2560d90dAll

元大-花蓮 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/04/02177.8000.0078.3011410.72%
2025/03/310.178.0200.0077.600.11420.09%
2025/03/26083.00082.6083.1001350.01%
2025/03/25083.0000.0082.7001370.02%
2025/03/24082.5000.0082.9001370.00%
2025/03/21483.2500.0083.0041382.89%
2025/03/18083.7000.0083.3001480.01%
2025/03/170.183.8000.0083.800.11510.07%
2025/02/270.286.8500.0086.700.21870.11%
2025/02/180.187.0000.0086.500.12330.03%
2025/02/17088.1000.0087.6002390.02%
2025/02/12086.8000.0086.4002800.00%
2025/02/040.184.4700.0083.800.12760.05%
2025/02/030.184.1000.0084.300.12740.03%
2025/01/200.184.8000.0084.800.12720.04%
2025/01/100.286.3000.0085.800.22590.09%
2025/01/020.289.9000.0090.200.22480.08%
2024/12/030.298.2000.0097.800.22160.09%
2024/11/290.196.2000.0096.200.11990.05%
2024/11/2600.00195.8095.50-1193-0.52%
2024/11/2500.00197.5097.60-1187-0.53%
2024/11/2200.000.797.5097.50-0.7181-0.39%
2024/11/1500.001.395.4895.50-1.3147-0.85%
2024/11/010.289.9000.0090.000.21140.17%
2024/10/010.290.0000.0091.000.21330.11%
2024/09/2400.00888.6088.80-8143-5.57%
2024/09/1900.000.588.0088.30-0.5148-0.32%
2024/09/06886.7500.0086.5081595.02%
2024/09/030.488.6000.0088.500.41640.21%
2024/08/0900.000.390.8091.00-0.3204-0.13%
2024/08/0600.00187.6088.90-1218-0.46%
2024/08/010.691.9800.0092.200.62040.27%
2024/07/09191.40191.5091.8002050.00%
2024/07/030.291.2000.0091.400.22060.11%
2024/07/020.291.1300.0091.200.22060.11%
2024/07/010.289.8000.0089.900.22030.08%
2024/06/24189.9000.0089.7012040.49%
2024/06/210.190.7000.0090.300.12060.06%
2024/06/040.192.6000.0092.500.12280.04%
2024/06/030.692.3600.0092.400.62310.27%
2024/05/290.192.5000.0092.300.12340.02%
2024/05/17193.9000.0093.9012300.43%
2024/04/16087.6000.0087.4002490.01%
2024/04/1200.00088.6088.500253-0.02%
水星生醫*攜手旭富製藥 簽訂MTA開發抗癲癇藥物Anue鉅亨-2024/04/15
旭富新產能到位本季營運看增 觀音新廠產能再增5成Anue鉅亨-2023/10/03
星國阿茲海默三期順利解盲 旭富獨供原料藥營運吞補丸Anue鉅亨-2022/11/23
旭富 相關文章
 
 
25小時27